Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cell Reports|May 26, 2024
CRACD loss induces neuroendocrine cell plasticity of lung adenocarcinomaBongjun Kim, Shengzhe Zhang, Yuanjian Huang, et al.
Gastroenterology|May 31, 2023
Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune EvasionKyung-Pil Ko, Yuanjian Huang, Shengzhe Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell CancerKyung-Pil Ko, Shengzhe Zhang, Yuanjian Huang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
CDH1 loss promotes diffuse-type gastric cancer tumorigenesis via epigenetic reprogramming and immune evasionGengyi Zou, Yuanjian Huang, Shengzhe Zhang, et al.
The Journal of Experimental Medicine|February 27, 2024
E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogrammingGengyi Zou, Yuanjian Huang, Shengzhe Zhang, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancerNicole A Kirk, Jin Ng, Kate-Lin Ly, et al.
Nature Communications|October 25, 2024
PCLAF-DREAM drives alveolar cell plasticity for lung regenerationBongjun Kim, Yuanjian Huang, Kyung-Pil Ko, et al.
Iscience|May 14, 2024
Tumor niche network-defined subtypes predict immunotherapy response of esophageal squamous cell cancerKyung-Pil Ko, Shengzhe Zhang, Yuanjian Huang, et al.
Molecular Cancer Research : MCR|January 5, 2026
SMARCA4 loss promotes late-stage tumor progression in non-neuroendocrine small-cell lung cancerNicole A Kirk, Jin Ng, Kate-Lin Ly, et al.
Pageof 3